Please check your internet connection and try again.
# Hyaluronic Acid
## Overview
Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan found in various connective tissues, including synovial fluid, skin, and cartilage. It acts as a lubricant and shock absorber. Formulations vary widely by indication and route of administration.
## Primary Indications
* **Intra-articular injection:** Osteoarthritis of the knee (symptomatic relief).
* **Ophthalmic solution:** Ocular lubrication for dry eye disease, post-operative wound healing (e.g., after cataract surgery).
* **Dermal filler:** Cosmetic enhancement (e.g., wrinkle reduction, lip augmentation).
* **Wound healing:** Various topical formulations.
## Adult Dosing
* **Intra-articular:** Varies significantly by product. Common regimens include:
* Single injection: 20 mg in 2 mL (10 mg/mL) once.
* Weekly injections: 20 mg in 2 mL (10 mg/mL) once weekly for 3-5 weeks.
* *Specific dosing depends on the product and local protocol.*
* **Ophthalmic:** Typically 1-2 drops instilled into the affected eye(s) as needed.
* **Dermal Filler:** Determined by the specific product, area treated, and desired effect. Administered by trained professionals.
## Pediatric Dosing
There is limited established pediatric dosing for most hyaluronic acid formulations. Intra-articular use is generally not recommended in children due to lack of data. Ophthalmic formulations may be used off-label for severe dry eye, with dosing guided by clinical response and physician discretion.
## Dose Adjustments
No dose adjustments are typically required for hepatic or renal impairment.
## Contraindications
* Known hypersensitivity to hyaluronic acid or any component of the formulation.
* Active joint infection or severe skin infection at the injection site for intra-articular use.
* Known hypersensitivity to gram-positive bacterial proteins (for some HA products derived from bacterial fermentation).
## Adverse Effects
* **Intra-articular:** Localized pain, swelling, stiffness, warmth at the injection site. Transient joint effusions.
* **Ophthalmic:** Temporary blurred vision, eye irritation, stinging, redness.
* **Dermal Filler:** Bruising, swelling, redness, itching, pain, nodules, infection, allergic reactions. Rare but serious complications include vascular occlusion.
## Key Drug Interactions
* **Intra-articular:** Concurrent intra-articular corticosteroids may limit the duration of HA action. Avoid concurrent use if possible.
* **Ophthalmic:** Topical ocular medications may be administered concurrently, but separate administration by at least 5 minutes is recommended.
## Monitoring
* **Intra-articular:** Monitor for signs of joint infection (fever, chills, increased joint pain and swelling). Assess for symptomatic improvement.
* **Ophthalmic:** Monitor for symptom relief of dry eye. Assess for signs of ocular irritation or infection.
* **Dermal Filler:** Monitor for local reactions, signs of infection, or vascular compromise.
## Clinical Pearls
* Hyaluronic acid for osteoarthritis aims to supplement synovial fluid, providing lubrication and cushioning. It does not alter the underlying disease process.
* The onset of pain relief with intra-articular HA can be delayed (several weeks) and may last for months.
* For ophthalmic use, preservative-free formulations are preferred for frequent or long-term use to minimize ocular surface toxicity.
* Dermal filler procedures require specialized training and should only be performed by qualified healthcare professionals.
---
*This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions.*
